Shigella flexneri

Last updated

Shigella flexneri
Shigella flexneri.tif
Shigella flexneri
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Pseudomonadota
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Shigella
Species:
S. flexneri
Binomial name
Shigella flexneri
Castellani & Chalmers 1919

Shigella flexneri is a species of Gram-negative bacteria in the genus Shigella that can cause diarrhea in humans. Several different serogroups of Shigella are described; S. flexneri belongs to group B. S. flexneri infections can usually be treated with antibiotics, although some strains have become resistant. Less severe cases are not usually treated because they become more resistant in the future. [1] Shigella are closely related to Escherichia coli, but can be differentiated from E.coli based on pathogenicity, physiology (failure to ferment lactose or decarboxylate lysine) and serology. [2]

Contents

Discovery

The species was named after the American physician Simon Flexner; the genus Shigella is named after Japanese physician Kiyoshi Shiga, who researched the cause of dysentery. Shiga entered the Tokyo Imperial University School of Medicine in 1892, during which he attended a lecture by Dr. Shibasaburo Kitasato. Shiga was impressed by Dr. Kitasato's intellect and confidence, so after graduating, he went to work for him as a research assistant at Institute for Infectious Diseases. In 1897, Shiga focused his efforts on what the Japanese referred to as a "Sekiri" (dysentery) outbreak. These epidemics were detrimental to the Japanese people and occurred often in the late 19th century. The 1897 sekiri epidemic affected >91,000, with a mortality rate of >20%. [3] Shiga studied 32 dysentery patients and used Koch's Postulates to successfully isolate and identify the bacterium causing the disease. He continued to study and characterize the bacterium, identifying its methods of toxin production i.e. Shiga Toxin, and worked tirelessly to create a vaccine for the disease.

Characterization

Morphology

Shigella flexneri is a rod shaped, nonflagellar bacterium that relies on actin-based motility. It produces the protein actin in a swift and continuous fashion to propel itself forward within and between the host's cells. [4] This bacterium is gram-negative, non-spore forming Shigella from serogroup B. There are 6 serotypes within this serogroup. [2]

Serotype

Shigella flexneri belongs to group B (i.e. agglutinate with B antisera) which further subclassified by six type-specific and four group-specific antisera. Until now at least 23 different subserotypes have been identified and reported. [5] PCR based molecular serotyping technique are now available targeting wzx1-5 (All except serotype 6) and gtr genes or wzx6 (Only serotype 6). [6]

SerotypePreviously designated nameType antigen specific antisera (MASF)MASFGroup antigen specific antisera (MASF)
IIIIV-2VVIIcBY-567,8IV-I
S. flexneri 1a1a+++
S. flexneri 1b1b+++
S. flexneri 1d1d+++
S. flexneri 2a2a+++
S. flexneri 2b2b+++
S. flexneri 3a3a+++
S. flexneri 3b3b++
S. flexneri 4a4a+++
S. flexneri 4b4b+++
S. flexneri 4c4c+++
S. flexneri 4dtype4+++
S. flexneri 4e4a, 4av++++
S. flexneri 5a5a+++
S. flexneri 5b5b+++
S. flexneri 6atype 6++
S. flexneri 6btype 6+++
S. flexneri 7a1c++
S. flexneri 7b1c+6+++
S. flexneri XaX++
S. flexneri XbXv+++
S. flexneri YaY++
S. flexneri YbYv+++
S. flexneri Z4X, 4s++

Invasion

Shigella flexneri is an intracellular bacterium that infects the epithelial lining of the mammalian intestinal tract. This bacterium is acid tolerant and can survive conditions of pH 2. Thus, it is able to enter the mouth of its host and survive passage through the stomach to the colon. [7] Once inside of the colon, S. flexneri can penetrate the epithelium in three ways: 1) The bacterium can alter the tight junctions between the epithelial cells, allowing it to cross into the sub-mucosa. 2) It can penetrate the highly endocytic M cells that are dispersed in the epithelial layer and cross into the sub-mucosa. 3) After reaching the sub-mucosa, the bacteria can be phagocytosed by macrophages and induce apoptosis, cell death. This releases cytokines that recruit polymorphonuclear cells (PMN) to the sub-mucosa. S. flexneri still in the lumen of the colon traverse the epithelial lining as the PMNs cross into the infected area. The influx of PMN cells across the epithelial layer in response to Shigella disrupts the integrity of the epithelium allowing lumenal bacteria to cross into the sub-mucosa in an M-cell independent mechanism. [8] S. flexneri uses these three methods to reach the sub-mucosa to penetrate the epilithelial cells from the basolateral side. The bacterium has four known invasion plasmid antigens: IpaA, IpaB, IpaC, and IpaD. When S. flexneri makes contact with the basolateral side of an epithelial cell, IpaC and IpaB are fused together to make a pore in the epithelial cell membrane. It then uses a type-III secretion system (T3SS) to insert the other Ipa proteins into the cytoplasm of the epithelial cell. [8] S. flexneri can pass to neighboring epithelial cells by using its own outer membrane protein, IcsA, to activate the host's actin assembly machinery. The IcsA protein is first localized to one pole of the bacterium where it will then bind with the host's protein, Neural Wiskott-Aldrich Syndrome Protein (N-WASP). This IcsA/N-WASP complex then activates the Actin-related protein (Arp) 2/3 Complex. Arp 2/3 Complex is the protein responsible for rapidly initiating actin polymerization and propelling the bacteria forward. [8] [2] [9] When S. flexneri reaches the adjoining membrane, it creates a protrusion into the neighboring cell's cytoplasm. The bacteria becomes surrounded by two layers of cellular membrane. It then uses another IpaBC complex to make a pore and enter the next cell. VacJ is a protein that is also needed by S. flexneri to exit the protrusion. Its exact function is still being studied but it is known that intercellular spread is greatly impaired without it. [8] [10] Bacterial replication within the epithelial cell is detrimental to the cell but it is proposed that epithelial cell death is largely due to the host's own inflammatory response. [8]

Genetics

The genome of S. flexneri and Escherichia coli are nearly indistinguishable at the species level. S. flexneri has a circular chromosome with 4,599,354 base pairs. It is smaller than that of E. coli but the genes are similar. S. flexneri has about 4,084 known genes in the genome. The extensive similarity between E. coli and S. flexneri is proposed to be due to horizontal transfer. All of the genes needed for S. flexneri to invade the epithelial lining of the colon are found on a virulence plasmid called pINV. The genome of pINV is highly conserved between subspecies of S. flexneri. S. flexneri also has two other small multicopy plasmids, but some strains of S. flexneri have more plasmids that are suspected to confer antibiotic resistance. [11] Some strains of S. flexneri have resistance to the antibiotics streptomycin, ampicillin, or trimethoprim. [12] It has been found that chloramphenicol, nalidixic acid, and gentamicin are still effective antibiotics for some strains. [13]

Metabolism

Shigella flexneri is a heterotroph. It utilizes the Embden-Meyerhof-Parnas (EMP), Entner-Doudoroff (ED), or pentose phosphate pathway (PPP) to metabolize sugars. The products of these pathways then feed into the Citric Acid Cycle (TCA). S. flexneri can metabolize glucose and pyruvate. Supplemented pyruvate allows for the most growth and is believed to be the preferred carbon source. Pyruvate could be supplied by the cell's own metabolism or taken from the host cell. S. flexneri is a facultative anaerobe that is able to perform mixed-acid fermentation of pyruvate. [14] [2] S. flexneri is unable to ferment lactose. [2] This bacterium grows optimally at 37 °C but can grow in temperatures as low as 30 °C. [13]

Small RNA

Bacterial small RNAs play important roles in many cellular processes. RnaG and RyhB sRNAs have been well studied in S. flexneri. [15] Ssr1 sRNA, which could play role in resistance to acidic stress and regulation of virulence was shown to exist only in Shigella. [16]

Ecology

Infectious cycle

Shigella flexneri contains a virulence plasmid that codes for three virulence factors: a type-3 secretion system (T3SS), invasion plasmid antigen proteins (IPA proteins), and IcsA (used for cell-to-cell spread). [17]

Upon infection, S. flexneri injects the host cell cytoplasm with ipa proteins using the T3SS—a needle-and-syringe-like apparatus common to many Gram-negative pathogens. These ipa proteins induce "membrane ruffling" by the host cell. Membrane ruffling creates membrane pockets which capture and engulf the bacteria. Once inside, S. flexneri uses host cell actin for propulsion to move directly from cell to cell using a cellular mechanism known as paracytophagy, [18] [19] similarly to the bacterial pathogen Listeria monocytogenes .

Shigella flexneri is able to inhibit the acute inflammatory response in the initial stage of infection [20] by using an effector protein, OspI, which is encoded by ORF169b on the Shigella large plasmid and secreted by the type III secretion system. It dampens the inflammatory response during bacterial invasion by suppressing the TNF-α-receptor-associated factor 6 (TRAF6)-mediated signalling pathway. [20] OspI has glutamine deamidase activity, and is able to selectively deaminate glutamine at position 100 in UBC13 to glutamate, and this results in a failure of the E2 ubiquitin-conjugating activity which is required for TRAF6 activation. [20]

Related Research Articles

<i>Salmonella</i> Genus of prokaryotes

Salmonella is a genus of rod-shaped (bacillus) gram-negative bacteria of the family Enterobacteriaceae. The two known species of Salmonella are Salmonella enterica and Salmonella bongori. S. enterica is the type species and is further divided into six subspecies that include over 2,600 serotypes. Salmonella was named after Daniel Elmer Salmon (1850–1914), an American veterinary surgeon.

<i>Shigella</i> Genus of bacteria

Shigella is a genus of bacteria that is Gram-negative, facultatively anaerobic, non–spore-forming, nonmotile, rod-shaped, and is genetically closely related to Escherichia. The genus is named after Kiyoshi Shiga, who discovered it in 1897.

<span class="mw-page-title-main">Shiga toxin</span> Family of related toxins

Shiga toxins are a family of related toxins with two major groups, Stx1 and Stx2, expressed by genes considered to be part of the genome of lambdoid prophages. The toxins are named after Kiyoshi Shiga, who first described the bacterial origin of dysentery caused by Shigella dysenteriae. Shiga-like toxin (SLT) is a historical term for similar or identical toxins produced by Escherichia coli. The most common sources for Shiga toxin are the bacteria S. dysenteriae and some serotypes of Escherichia coli (STEC), which includes serotypes O157:H7, and O104:H4.

Virulence is a pathogen's or microorganism's ability to cause damage to a host.

<i>Listeria monocytogenes</i> Species of pathogenic bacteria that causes the infection listeriosis

Listeria monocytogenes is the species of pathogenic bacteria that causes the infection listeriosis. It is a facultative anaerobic bacterium, capable of surviving in the presence or absence of oxygen. It can grow and reproduce inside the host's cells and is one of the most virulent foodborne pathogens: 20 to 30% of foodborne listeriosis infections in high-risk individuals may be fatal. In the European Union, listeriosis follows an upward trend that began in 2008, causing 2,161 confirmed cases and 210 reported deaths in 2014, 16% more than in 2013. Listeriosis mortality rates are also higher in the EU than for other foodborne pathogens. Responsible for an estimated 1,600 illnesses and 260 deaths in the United States annually, listeriosis ranks third in total number of deaths among foodborne bacterial pathogens, with fatality rates exceeding even Salmonella spp. and Clostridium botulinum.

Bacillary dysentery is a type of dysentery, and is a severe form of shigellosis. It is associated with species of bacteria from the family Enterobacteriaceae. The term is usually restricted to Shigella infections.

<i>Burkholderia cenocepacia</i> Species of bacterium

Burkholderia cenocepacia is a Gram-negative, rod-shaped bacterium that is commonly found in soil and water environments and may also be associated with plants and animals, particularly as a human pathogen. It is one of over 20 species in the Burkholderia cepacia complex (Bcc) and is notable due to its virulence factors and inherent antibiotic resistance that render it a prominent opportunistic pathogen responsible for life-threatening, nosocomial infections in immunocompromised patients, such as those with cystic fibrosis or chronic granulomatous disease. The quorum sensing systems CepIR and CciIR regulate the formation of biofilms and the expression of virulence factors such as siderophores and proteases. Burkholderia cenocepacia may also cause disease in plants, such as in onions and bananas. Additionally, some strains serve as plant growth-promoting rhizobacteria.

The AB5 toxins are six-component protein complexes secreted by certain pathogenic bacteria known to cause human diseases such as cholera, dysentery, and hemolytic–uremic syndrome. One component is known as the A subunit, and the remaining five components are B subunits. All of these toxins share a similar structure and mechanism for entering targeted host cells. The B subunit is responsible for binding to receptors to open up a pathway for the A subunit to enter the cell. The A subunit is then able to use its catalytic machinery to take over the host cell's regular functions.

<span class="mw-page-title-main">Type III secretion system</span> Protein appendage

The type III secretion system, also called the injectisome, is one of the bacterial secretion systems used by bacteria to secrete their effector proteins into the host's cells to promote virulence and colonisation. The T3SS is a needle-like protein complex found in several species of pathogenic gram-negative bacteria.

Porphyromonas gingivalis belongs to the phylum Bacteroidota and is a nonmotile, Gram-negative, rod-shaped, anaerobic, pathogenic bacterium. It forms black colonies on blood agar.

<span class="mw-page-title-main">Virulence-related outer membrane protein family</span>

Virulence-related outer membrane proteins, or outer surface proteins (Osp) in some contexts, are expressed in the outer membrane of gram-negative bacteria and are essential to bacterial survival within macrophages and for eukaryotic cell invasion.

<span class="mw-page-title-main">Clostridium difficile toxin A</span>

Clostridium difficile toxin A (TcdA) is a toxin generated by Clostridioides difficile, formerly known as Clostridium difficile. It is similar to Clostridium difficile Toxin B. The toxins are the main virulence factors produced by the gram positive, anaerobic, Clostridioides difficile bacteria. The toxins function by damaging the intestinal mucosa and cause the symptoms of C. difficile infection, including pseudomembranous colitis.

<span class="mw-page-title-main">Philippe Sansonetti</span>

Philippe J. Sansonetti is a French microbiologist, professor at the Pasteur Institute and the Collège de France in Paris. He is the director of the Inserm Unit 786 and of the Institut Pasteur laboratory Pathogénie Microbienne Moléculaire.

Paracytophagy is the cellular process whereby a cell engulfs a protrusion which extends from a neighboring cell. This protrusion may contain material which is actively transferred between the cells. The process of paracytophagy was first described as a crucial step during cell-to-cell spread of the intracellular bacterial pathogen Listeria monocytogenes, and is also commonly observed in Shigella flexneri. Paracytophagy allows these intracellular pathogens to spread directly from cell to cell, thus escaping immune detection and destruction. Studies of this process have contributed significantly to our understanding of the role of the actin cytoskeleton in eukaryotic cells.

Interspecies quorum sensing is a type of quorum sensing in which bacteria send and receive signals to other species besides their own. This is accomplished by the secretion of signaling molecules which trigger a response in nearby bacteria at high enough concentrations. Once the molecule hits a certain concentration it triggers the transcription of certain genes such as virulence factors. It has been discovered that bacteria can not only interact via quorum sensing with members of their own species but that there is a kind of universal molecule that allows them to gather information about other species as well. This universal molecule is called autoinducer 2 or AI-2.

Enteroaggregative Escherichia coli are a pathotype of Escherichia coli which cause acute and chronic diarrhea in both the developed and developing world. They may also cause urinary tract infections. EAEC are defined by their "stacked-brick" pattern of adhesion to the human laryngeal epithelial cell line HEp-2. The pathogenesis of EAEC involves the aggregation of and adherence of the bacteria to the intestinal mucosa, where they elaborate enterotoxins and cytotoxins that damage host cells and induce inflammation that results in diarrhea.

Bacterial effectors are proteins secreted by pathogenic bacteria into the cells of their host, usually using a type 3 secretion system (TTSS/T3SS), a type 4 secretion system (TFSS/T4SS) or a Type VI secretion system (T6SS). Some bacteria inject only a few effectors into their host’s cells while others may inject dozens or even hundreds. Effector proteins may have many different activities, but usually help the pathogen to invade host tissue, suppress its immune system, or otherwise help the pathogen to survive. Effector proteins are usually critical for virulence. For instance, in the causative agent of plague, the loss of the T3SS is sufficient to render the bacteria completely avirulent, even when they are directly introduced into the bloodstream. Gram negative microbes are also suspected to deploy bacterial outer membrane vesicles to translocate effector proteins and virulence factors via a membrane vesicle trafficking secretory pathway, in order to modify their environment or attack/invade target cells, for example, at the host-pathogen interface.

<span class="mw-page-title-main">RnaG</span>

RnaG is a small regulatory non-coding RNA encoded by the virulence plasmid of Shigella flexneri, a Gram-negative pathogenic bacterium that causes human bacillary dysentery. It is a first regulatory RNA characterised in S. flexneri. The RNA is 450 nucleotides long and it contains a region with specific secondary structure that interacts with icsA mRNA and forms a transcription terminator. Acting as antisense, RnaG is transcribed from the complementary strand of its target, icsA mRNA. The activity of the incA protein is crucial for spreading of the bacterial pathogen in the host cells.

<span class="mw-page-title-main">Nucleomodulin</span>

Nucleomodulins are a family of bacterial proteins that enter the nucleus of eukaryotic cells.

<span class="mw-page-title-main">Virginia L. Miller</span> American microbiologist

Virginia L. Miller is a microbiologist known for her work on studying the factors leading to disease caused by bacteria. Miller is an elected fellow of the American Academy of Microbiology (2003) and a former Pew Charitable Trust Biomedical Scholar (1989).

References

  1. ↑ Ryan KJ; Ray CG; Sherris JC, eds. (2004). Sherris Medical Microbiology (4th ed.). New York: McGraw-Hill. ISBN   978-0-8385-8529-0. LCCN   2003054180. OCLC   52358530.
  2. 1 2 3 4 5 Hale, Thomas L.; Keusch, Gerald T. (1996), Baron, Samuel (ed.), "Shigella", Medical Microbiology (4th ed.), University of Texas Medical Branch at Galveston, ISBN   978-0-9631172-1-2, PMID   21413292 , retrieved 2020-04-23
  3. ↑ Trofa, Andrew F.; Ueno-Olsen, Hannah; Oiwa, Ruiko; Yoshikawa, Masanosuke (1999-11-01). "Dr. Kiyoshi Shiga: Discoverer of the Dysentery Bacillus". Clinical Infectious Diseases. 29 (5): 1303–1306. doi: 10.1086/313437 . ISSN   1058-4838. PMID   10524979.
  4. ↑ Goldberg, Marcia B. (December 2001). "Actin-Based Motility of Intracellular Microbial Pathogens". Microbiology and Molecular Biology Reviews. 65 (4): 595–626. doi:10.1128/MMBR.65.4.595-626.2001. ISSN   1092-2172. PMC   99042 . PMID   11729265.
  5. ↑ Shahnaij, Mohammad; Latif, Hasan A.; Azmi, Ishrat J.; Amin, Mohammed Badrul; Luna, Sharmin J.; Islam, Mohammad Aminul; Talukder, Kaisar Ali (2018). "Characterization of a serologically atypical Shigella flexneri Z isolated from diarrheal patients in Bangladesh and a proposed serological scheme for Shigella flexneri". PLOS ONE. 13 (8): e0202704. Bibcode:2018PLoSO..1302704S. doi: 10.1371/journal.pone.0202704 . ISSN   1932-6203. PMC   6108489 . PMID   30142163.
  6. ↑ Brengi, Silvina P.; Sun, Qiangzheng; Bolaños, Hilda; Duarte, Francisco; Jenkins, Claire; Pichel, Mariana; Shahnaij, Mohammad; Sowers, Evangeline G.; Strockbine, Nancy; Talukder, Kaisar A.; Derado, Gordana; Viñas, María Rosa; Kam, Kai Man; Xu, Jianguo; Onderdonk, Andrew B. (2019). "PCR-Based Method for Shigella flexneri Serotyping: International Multicenter Validation". Journal of Clinical Microbiology. 57 (4): e01592-18. doi:10.1128/JCM.01592-18. ISSN   0095-1137. PMC   6440786 . PMID   30700505.
  7. ↑ Bagamboula, C. F.; Uyttendaele, M.; Debevere, J. (2002). "Acid tolerance of Shigella sonnei and Shigella flexneri". Journal of Applied Microbiology. 93 (3): 479–486. doi:10.1046/j.1365-2672.2002.01714.x. ISSN   1365-2672. PMID   12174047. S2CID   44572279.
  8. 1 2 3 4 5 Jennison, Amy V.; Verma, Naresh K. (2004-02-01). "Shigella flexneri infection: pathogenesis and vaccine development". FEMS Microbiology Reviews. 28 (1): 43–58. doi:10.1016/j.femsre.2003.07.002. ISSN   0168-6445. PMID   14975529.
  9. ↑ Egile, Coumaran; Loisel, Thomas P.; Laurent, Valérie; Li, Rong; Pantaloni, Dominique; Sansonetti, Philippe J.; Carlier, Marie-France (1999-09-20). "Activation of the Cdc42 Effector N-Wasp by the Shigella flexneri Icsa Protein Promotes Actin Nucleation by Arp2/3 Complex and Bacterial Actin-Based Motility". Journal of Cell Biology. 146 (6): 1319–1332. doi: 10.1083/jcb.146.6.1319 . ISSN   0021-9525. PMC   2156126 . PMID   10491394.
  10. ↑ Carpenter, Chandra D.; Cooley, Benjamin J.; Needham, Brittany D.; Fisher, Carolyn R.; Trent, M. Stephen; Gordon, Vernita; Payne, Shelley M. (2014-02-01). "The Vps/VacJ ABC Transporter Is Required for Intercellular Spread of Shigella flexneri". Infection and Immunity. 82 (2): 660–669. doi:10.1128/IAI.01057-13. ISSN   0019-9567. PMC   3911398 . PMID   24478081.
  11. ↑ Wei, J.; Goldberg, M. B.; Burland, V.; Venkatesan, M. M.; Deng, W.; Fournier, G.; Mayhew, G. F.; Plunkett, G.; Rose, D. J.; Darling, A.; Mau, B. (2003-05-01). "Complete Genome Sequence and Comparative Genomics of Shigella flexneri Serotype 2a Strain 2457T". Infection and Immunity. 71 (5): 2775–2786. doi:10.1128/IAI.71.5.2775-2786.2003. ISSN   0019-9567. PMC   153260 . PMID   12704152.
  12. ↑ Pan, Jing-Cao; Ye, Rong; Meng, Dong-Mei; Zhang, Wei; Wang, Hao-Qiu; Liu, Ke-Zhou (2006-08-01). "Molecular characteristics of class 1 and class 2 integrons and their relationships to antibiotic resistance in clinical isolates of Shigella sonnei and Shigella flexneri". Journal of Antimicrobial Chemotherapy. 58 (2): 288–296. doi:10.1093/jac/dkl228. ISSN   0305-7453. PMID   16766536.
  13. 1 2 Oaks, E. V.; Wingfield, M. E.; Formal, S. B. (1985-04-01). "Plaque formation by virulent Shigella flexneri". Infection and Immunity. 48 (1): 124–129. doi:10.1128/IAI.48.1.124-129.1985. ISSN   0019-9567. PMC   261924 . PMID   3884506.
  14. ↑ Waligora, E. A.; Fisher, C. R.; Hanovice, N. J.; Rodou, A.; Wyckoff, E. E.; Payne, S. M. (2014-07-01). "Role of Intracellular Carbon Metabolism Pathways in Shigella flexneri Virulence". Infection and Immunity. 82 (7): 2746–2755. doi:10.1128/IAI.01575-13. ISSN   0019-9567. PMC   4097621 . PMID   24733092.
  15. ↑ Peng, Junping; Yang, Jian; Jin, Qi (2011-04-05). "An Integrated Approach for Finding Overlooked Genes in Shigella". PLOS ONE. 6 (4): e18509. Bibcode:2011PLoSO...618509P. doi: 10.1371/journal.pone.0018509 . ISSN   1932-6203. PMC   3071730 . PMID   21483688.
  16. ↑ Wang, Ligui; Yang, Guang; Qi, Lihua; Li, Xiang; Jia, Leili; Xie, Jing; Qiu, Shaofu; Li, Peng; Hao, RongZhang (2016-01-01). "A Novel Small RNA Regulates Tolerance and Virulence in Shigella flexneri by Responding to Acidic Environmental Changes". Frontiers in Cellular and Infection Microbiology. 6: 24. doi: 10.3389/fcimb.2016.00024 . ISSN   2235-2988. PMC   4782007 . PMID   27014636.
  17. ↑ Stevens J; Galyov EE; Stevens MP (2006). "Actin-dependent movement of bacterial pathogens". Nature Reviews Microbiology. 4 (2): 91–101. doi: 10.1038/nrmicro1320 . PMID   16415925. S2CID   30946244.
  18. ↑ Ogawa M; Handa Y; Ashida H; Suzuki M; Sasakawa C (2008). "The versatility of Shigella effectors". Nature Reviews Microbiology. 6 (1): 11–16. doi:10.1038/nrmicro1814. PMID   18059288. S2CID   26214256.
  19. ↑ Robbins JR; Barth AI; Marquis H; de Hostos EL; Nelson WJ; Theriot JA (1999). "Listeria monocytogenes exploits normal host cell processes to spread from cell to cell". Journal of Cell Biology. 146 (6): 1333–1350. doi:10.1083/jcb.146.6.1333. PMC   1785326 . PMID   10491395.
  20. 1 2 3 Sanada T; Kim M; Mimuro H; Suzuki M; Ogawa M; Oyama A; Ashida H; Kobayashi T; Koyama T; Nagai S; Shibata Y; Gohda J; Inoue J; Mizushima T; Sasakawa C (2012). "The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response". Nature. 483 (7391): 623–6. Bibcode:2012Natur.483..623S. doi:10.1038/nature10894. PMID   22407319. S2CID   4371539.

nora https://microbenotes.com/biochemical-test-of-shigella-flexneri/

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.